The pharmaceutical large narrowed its full-year steering after its blockbuster Wegovy weight-loss drug beat gross sales expectations within the third quarter.
in Business
Novo Nordisk's Wegovy Sales Beat Expectations
Don't have an account? Register
Enter your account data and we will send you a link to reset your password.
To use social login you have to agree with the storage and handling of your data by this website. GDPR Privacy policy
AcceptHere you'll find all collections you've created before.
